Literature DB >> 6606513

Binding of immunoglobulins and immune complexes to cartilage derived extracts.

W R Alomari, J R Archer, R Brocklehurst, H L Currey.   

Abstract

Cartilage extracts with affinity for heat aggregated immunoglobulins were prepared from human articular and bovine nasal cartilage. These extracts, containing predominantly collagen, also bound both to immune complexes (IC) prepared in vitro and to immunoglobulins from sera of many patients with rheumatoid arthritis (RA). Cryoprecipitation of rheumatoid sera removed material reacting with the extract and density gradient fractionation of a positive serum showed correlation between binding to the extract and to C1q. These results indicate that the binding materials in rheumatoid sera were likely to be IC. We suggest that some assays which apparently demonstrate anti-collagen autoantibodies in fact measure IC. These findings also have implications for models of the pathogenesis of RA.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6606513      PMCID: PMC1536165     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Agglutination of IgG-coated particles by collagen.

Authors:  Y Eeckhout; C L Cambiaso; H Riccomi; G Vaes; P L Masson
Journal:  FEBS Lett       Date:  1979-11-01       Impact factor: 4.124

2.  Antigen retention in joint tissues in antigen-induced synovitis.

Authors:  J R Hollister; M Mannik
Journal:  Clin Exp Immunol       Date:  1974-04       Impact factor: 4.330

3.  Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues.

Authors:  T D Cooke; E R Hurd; H E Jasin; J Bienenstock; M Ziff
Journal:  Arthritis Rheum       Date:  1975 Nov-Dec

4.  Effect of EDTA on the solid phase Clq immune complex assay.

Authors:  M P Davey; L Korngold
Journal:  Int Arch Allergy Appl Immunol       Date:  1982

5.  The effect of IgG aggregate size and concentration on reactivity in immune complex assays.

Authors:  D McCarthy; D H Goddard; E J Holborow; A C Horsfall; P A Mumford; R N Maini
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

6.  Enzyme-linked immunosorbent microassay for quantification of specific antibodies to collagen type I, II, III.

Authors:  B Gosslau; H J Barrach
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

7.  Evaluation of different methods for detecting circulating immune complexes. Studies in patients with lung cancer.

Authors:  G Füst; B Fekete; I Angyal; A Jakab; A Pál; K Merétey; A Falus; K Török; G Szegedi; M Kávai; E Puskás; M Csécsi-Nagy; T Szabó; A Lenkey; M Misz
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

8.  Mechanism of trapping of immune complexes in joint collagenous tissues.

Authors:  H E Jasin
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

9.  Anomalous reactions in the haemagglutination assay for anti-collagen antibodies: studies on patients with rheumatoid arthritis or chronic low back pain.

Authors:  H K Beard; D J Lea; R Ryvar
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

10.  Autoimmunity to type II collagen an experimental model of arthritis.

Authors:  D E Trentham; A S Townes; A H Kang
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

  10 in total
  3 in total

1.  The binding of immunoglobulin Fc to cationic proteins.

Authors:  S Pambakian; R N Poston
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

2.  Synovial fluid and peripheral blood immune complexes of patients with rheumatoid arthritis induce apoptosis in cytokine-activated chondrocytes.

Authors:  A J Schuerwegh; E J Dombrecht; W J Stevens; J F Van Offel; M M Kockx; C H Bridts; L S De Clerck
Journal:  Rheumatol Int       Date:  2007-04-03       Impact factor: 2.631

3.  Pepsinogen--an immunoglobulin binding artefact in 'collagen' preparations.

Authors:  A P Kirk; B P O'Hara; R A Mageed; M S McMahon; D McCarthy; S Menashi; J R Archer; H L Currey
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.